Investigation Report on China’s Rabeprazole Market 2021-2025

$2,600$3,900

According to CRI’s market research, the sales value of Rabeprazole in the Chinese market increased year by year from 2016 to 2019.

Clear

Description

Rabeprazole is a kind of proton pump inhibitor (PPI) gastric acid inhibitor. It is used for the treatment of gastroesophageal reflux disease and maintenance treatment after recovery. It is also suitable for the treatment of duodenal ulcers and Zollinger-Ellison syndrome. Rabeprazole’s product PARIET, developed by Eisai Pharmaceutical Co., Ltd. of Japan, was approved in China in 2000. As of the end of 2020, there are more than 10 manufacturers in the Chinese Rabeprazole market, of which Jiangsu Aosaikang Pharmaceutical Co., Ltd. accounts for the largest market share.

According to CRI’s market research, the sales value of Rabeprazole in the Chinese market increased year by year from 2016 to 2019. Due to the impact of the COVID-19 epidemic on the overall medical diagnosis and treatment services, the sales value decreased to CNY1.334 billion in 2020, with a year-on-year decrease of 11.01%. The CAGR of the sales value of Rabeprazole from 2016 to 2020 is 9.66% in China.

CRI predicts that the sales of Rabeprazole will have a restorative growth from 2021 to 2025 with the effective alleviation of the Covid-19 epidemic. At the same time, only Rabeprazole injections among the six PPI injections listed in China are not listed in the national medical insurance catalog as of the first half of 2021. It may enter medical insurance in the future, prompting sales to continue to increase. In addition, Rabeprazole has no obvious individual differences. Rabeprazole has stabler efficacy and has less interaction with other drugs compared with similar drugs,. Based on these advantages, it is expected that the sales of Rabeprazole in the Chinese market will continue to rise from 2021 to 2025.

Topics Covered:
-The impact of COVID-19 on China’s Rabeprazole market
– Sales value of China’s Rabeprazole 2016-2020
– Competitive landscape of China’s Rabeprazole market
– Prices of Rabeprazole in China
– Prices of Rabeprazole in China by regions and manufacturers
– Analysis of factors affecting the development of China’s Rabeprazole market
– Prospect of China’s Rabeprazole market from 2021 to 2025

Additional information

Publisher

Date Published

Pages

Charts

Format

Table of Contents

1 Relevant Concept of Rabeprazole
1.1 Indications for Rabeprazole
1.2 Development of Rabeprazole in China
1.3 Governmental Approval of Rabeprazole in China
1.4 The Impact of COVID-19 on Rabeprazole sales in China

2 Sales of Rabeprazole in China, 2016-2020
2.1 Sales Value of Rabeprazole
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Rabeprazole
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Rabeprazole by Dosage Form in China, 2016-2020
2.3.1 Injection
2.3.2 Tablets
2.3.3 Enteric-coated Tablets
2.3.4 Enteric-coated Capsules

3 Analysis of Major Rabeprazole Manufacturers in China in 2020
3.1 Analysis of Market Share of Major Rabeprazole Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Jiangsu Aosaikang Pharmaceutical Co.,Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of Aojiaming (Jiangsu Aosaikang Pharmaceutical Co., Ltd.’s Rabeprazole) in China
3.3 Nanjing Chang’ao Pharmaceutical Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Aoboping (Nanjing Chang’ao Pharmaceutical Co., Ltd.’s Rabeprazole) in China
3.4 Jichuan Pharmaceutical Group Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of JUMPCAN (Jichuan Pharmaceutical Group Co., Ltd.’s Rabeprazole) in China
3.5 Eisai (China) Pharmaceutical Co., Ltd.
3.5.1 Enterprise Profile
3.5.2 Sales of PARIET (Eisai (China) Pharmaceutical Co., Ltd.’s Rabeprazole) in China
3.6 Shandong Luoxin Pharmaceutical Group Co., Ltd.
3.6.1 Enterprise Profile
3.6.2 Sales of Kapeilai (Shandong Luoxin Pharmaceutical Group Co., Ltd.’s Rabeprazole) in China

4 Prices of Rabeprazole for Different Manufacturers in China, 2020-2021
4.1 Jiangsu Aosaikang Pharmaceutical Co., Ltd. (Aojiaming)
4.2 Nanjing Chang’ao Pharmaceutical Co., Ltd. (Aoboping)
4.3 Jichuan Pharmaceutical Group Co., Ltd. (JUMPCAN)
4.4 Eisai (China) Pharmaceutical Co., Ltd. (PARIET)
4.5 Shandong Luoxin Pharmaceutical Group Co., Ltd. (Kapeilai)

5 Prospect of Chinese Rabeprazole Market, 2021-2025
5.1 Influential Factors of Chinese Rabeprazole Market Development
5.1.1 The Impact of COVID-19 on Chinese Rabeprazole Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend

List of Charts
Chart Patent Information About Rabeprazole Injection Registration in China
Chart Patent Information About Rabeprazole Tablets Registration in China
Chart Patent Information About Rabeprazole Enteric-coated Tablets Registration in China
Chart Patent Information About Rabeprazole Enteric-coated Capsules Registration in China
Chart Sales Value of Rabeprazole Injection over the World
Chart Sales Value of Rabeprazole Tablets over the World
Chart Sales Value of Rabeprazole Enteric-coated Tablets over the World
Chart Sales Value of Rabeprazole Enteric-coated Capsules over the World
Chart Sales Value of Rabeprazole Injection in China, 2016-2020
Chart Sales Value of Rabeprazole Tablets in China, 2016-2020
Chart Sales Value of Rabeprazole Enteric-coated Tablets in China, 2016-2020
Chart Sales Value of Rabeprazole Enteric-coated Capsules in China, 2016-2020
Chart Sales Value of Rabeprazole Injection in China by Regions, 2016-2020
Chart Sales Value of Rabeprazole Tablets in China by Regions, 2016-2020
Chart Sales Value of Rabeprazole Enteric-coated Tablets in China by Regions, 2016-2020
Chart Sales Value of Rabeprazole Enteric-coated Capsules in China by Regions, 2016-2020
Chart Sales Volume of Rabeprazole Injection in China, 2016-2020
Chart Sales Volume of Rabeprazole Tablets in China, 2016-2020
Chart Sales Volume of Rabeprazole Enteric-coated Tablets in China, 2016-2020
Chart Sales Volume of Rabeprazole Enteric-coated Capsules in China, 2016-2020
Chart Sales Volume of Rabeprazole Injection in China by Regions, 2016-2020
Chart Sales Volume of Rabeprazole Tablets in China by Regions, 2016-2020
Chart Sales Volume of Rabeprazole Enteric-coated Tablets in China by Regions, 2016-2020
Chart Sales Volume of Rabeprazole Enteric-coated Capsules in China by Regions, 2016-2020
Chart Market Share by Sales Value of Top Rabeprazole Injection Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Rabeprazole Tablets Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Rabeprazole Enteric-coated Tablets Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Rabeprazole Enteric-coated Capsules Manufacturers in China, 2016-2020
Chart Sales Value and Volume of Aojiaming in China, 2016-2020
Chart Sales Value and Volume of Aoboping in China, 2016-2020
Chart Sales Value and Volume of JUMPCAN, 2016-2020
Chart Sales Value and Volume of PARIET in China, 2016-2020
Chart Sales Value and Volume of Kapeilai in China, 2016-2020
Chart Referential Prices of Aojiaming in China by Region, 2020-2021
Chart Referential Prices of Aoboping in China by Region, 2020-2021
Chart Referential Prices of JUMPCAN, 2020-2021
Chart Referential Prices of PARIET in China by Region, 2020-2021
Chart Referential Prices of Kapeilai in China by Region, 2020-2021
Chart Forecast on Sales Value of Rabeprazole Injection in China, 2021-2025
Chart Forecast on Sales Value of Rabeprazole Tablets in China, 2021-2025
Chart Forecast on Sales Value of Rabeprazole Enteric-coated Tablets in China, 2021-2025
Chart Forecast on Sales Value of Rabeprazole Enteric-coated Capsules in China, 2021-2025
Chart Forecast on Sales Volume of Rabeprazole Injection in China, 2021-2025
Chart Forecast on Sales Volume of Rabeprazole Tablets in China, 2021-2025
Chart Forecast on Sales Volume of Rabeprazole Enteric-coated Tablets in China, 2021-2025
Chart Forecast on Sales Volume of Rabeprazole Enteric-coated Capsules in China, 2021-2025